Literature DB >> 15365152

Infantile neuroaxonal dystrophy and pantothenate-kinase-associated neurodegeneration: locus heterogeneity.

K Hörtnagel1, N Nardocci, G Zorzi, B Garavaglia, E Botz, T Meitinger, T Klopstock.   

Abstract

Common clinical, radiologic, and pathologic features in infantile neuroaxonal dystrophy (INAD) and pantothenate kinase-associated neurodegeneration (PKAN) have led to the hypothesis of an allelic relationship. With the discovery of the gene defect in PKAN, this can now be tested directly. The authors excluded linkage in one consanguineous INAD family by haplotype analysis. Moreover, sequencing in seven INAD families revealed no mutations in PANK2 or in other genes of CoA biogenesis. Thus, INAD and PKAN are genetically heterogeneous disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365152     DOI: 10.1212/01.wnl.0000137046.28085.b2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Molecular diagnosis of infantile Neuro axonal Dystrophy by Next Generation Sequencing.

Authors:  Manisha Goyal; Sunita Bijarnia-Mahay; Stephen Kingsmore; Emily Farrow; Carol Saunders; Renu Saxena; Ishwar C Verma
Journal:  Indian J Pediatr       Date:  2014-10-29       Impact factor: 1.967

2.  PLA2G6 mutation underlies infantile neuroaxonal dystrophy.

Authors:  Shareef Khateeb; Hagit Flusser; Rivka Ofir; Ilan Shelef; Ginat Narkis; Gideon Vardi; Zamir Shorer; Rachel Levy; Aharon Galil; Khalil Elbedour; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2006-09-19       Impact factor: 11.025

3.  A deletion mutation in Slc12a6 is associated with neuromuscular disease in gaxp mice.

Authors:  Yan Jiao; Xiudong Jin; Jian Yan; Chi Zhang; Feng Jiao; Xinmin Li; Bruce A Roe; David B Mount; Weikuan Gu
Journal:  Genomics       Date:  2008-03-14       Impact factor: 5.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.